Department of Neurobiology, Care Sciences and Society (NVS), Division of Neurogeriatrics, Karolinska Institutet, 141 83 Huddinge, Sweden.
Ultrasound and Elasticity Imaging Laboratory, Department of Biomedical Engineering, Columbia University, NY, New York, USA.
Mol Cell Neurosci. 2020 Jun;105:103498. doi: 10.1016/j.mcn.2020.103498. Epub 2020 May 8.
The BRICHOS domain is found in human precursor proteins associated with cancer, dementia (Bri2) and amyloid lung disease (proSP-C). Recombinant human (rh) proSP-C and Bri2 BRICHOS domains delay amyloid-β peptide (Aβ) fibril formation and reduce associated toxicity in vitro and their overexpression reduces Aβ neurotoxicity in animal models of Alzheimer's disease. After intravenous administration in wild-type mice, rh Bri2, but not proSP-C, BRICHOS was detected in the brain parenchyma, suggesting that Bri2 BRICHOS selectively bypasses the blood-brain barrier (BBB). Here, our objective was to increase the brain delivery of rh proSP-C (trimer of 18 kDa subunits) and Bri2 BRICHOS (monomer to oligomer of 15 kDa subunits) using focused ultrasound combined with intravenous microbubbles (FUS + MB), which enables targeted and transient opening of the BBB. FUS + MB was targeted to one hemisphere of wild type mice and BBB opening in the hippocampal region was confirmed by magnetic resonance imaging. Two hours after FUS + MB brain histology showed no signs of tissue damage and immunohistochemistry showed abundant delivery to the brain parenchyma in 13 out of 16 cases given 10 mg/kg of proSP-C or Bri2 BRICHOS domains. The Bri2, but not proSP-C BRICHOS domain was detected also in the non-targeted hemisphere. ProSP-C and Bri2 BRICHOS domains were taken up by a subset of neurons in the hippocampus and cortex, and were detected to a minor extent in early endosomes. These results indicate that rh Bri2, but not proSP-C, BRICHOS, can be efficiently delivered into the mouse brain parenchyma and that both BRICHOS domains can be internalized by cell-specific mechanisms.
BRICHOS 结构域存在于与癌症、痴呆症(Bri2)和淀粉样肺疾病(proSP-C)相关的人类前体蛋白中。重组人 proSP-C 和 Bri2 BRICHOS 结构域可延缓淀粉样β肽(Aβ)纤维形成,并减少体外相关毒性,其过表达可降低阿尔茨海默病动物模型中的 Aβ 神经毒性。在野生型小鼠中静脉给药后,rh Bri2,但不是 proSP-C,BRICHOS 被检测到在脑实质中,这表明 Bri2 BRICHOS 选择性地绕过血脑屏障(BBB)。在这里,我们的目标是使用聚焦超声联合静脉微泡(FUS+MB)增加 rh proSP-C(18 kDa 亚基三聚体)和 Bri2 BRICHOS(15 kDa 亚基单体到低聚物)的脑内递送,这使得 BBB 的靶向和瞬时开放成为可能。FUS+MB 靶向野生型小鼠的一侧半球,通过磁共振成像确认了海马区 BBB 的开放。FUS+MB 给药后 2 小时,脑组织学未见组织损伤迹象,免疫组织化学显示 16 例中有 13 例给予 10mg/kg proSP-C 或 Bri2 BRICHOS 结构域后,大量药物递送到脑实质。还在非靶向半球检测到 Bri2,但不是 proSP-C BRICHOS 结构域。ProSP-C 和 Bri2 BRICHOS 结构域被海马和皮质中的一组神经元摄取,并在早期内体中检测到少量。这些结果表明,rh Bri2,但不是 proSP-C,BRICHOS,可以有效地递送到小鼠脑实质中,并且两种 BRICHOS 结构域都可以通过细胞特异性机制内化。